Intelligent Medical Objects’ Survey Unveils 94% of Provider Leaders Plan to Invest in Software This Year 90% of Hospital Providers Lost Revenue Due to Inefficient Data Use 98% openly acknowledged that ...

Intelligent Medical Objects, a Rosemont medical data firm that took a $1.5 billion private-equity deal last year, is buying a Texas-based artificial intelligence startup, a move it says will help it ...

Ottawa, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The global intelligent medical software market size is calculated at USD 5.59 billion in 2026 and is expected to reach around USD 22.33 billion by 2035, ...

Among the fields mushrooming at a very high speed, medicine is one of the trending. It is rapidly growing now, primarily through the application of digital means. Digital health software development ...

CystoSmart™, an AI software tool for bladder tumor detection in patients undergoing screening and surveillance endoscopic examination of the bladder is brand agnostic and compatible with flexible and ...

NORTHBROOK, Ill.--(BUSINESS WIRE)-- Intelligent Medical Objects (IMO ®), the leading provider of medical vocabulary services, announces today the availability of its IMO® Problem (IT) and IMO® ...

Intelligent Medical Objects, a Rosemont, IL-based medical data company, has sold a majority stake to Boston-based private-equity firm Thomas H. Lee Partners in a deal worth more than $1.5 billion. The ...

With stringent regulations and limited cleanroom space, scaling medical device production is no easy feat. Learn how a modular assembly system powered by Rockwell Automation’s MagneMover Lite ...

Canon Medical Components USA (CMCU) - Digital Radiography (DR) (https://mcu.canon), global leaders in advanced flat panel detectors (FPDs), X-ray components, X-ray tubes, and innovative imaging ...

CHICAGO--(BUSINESS WIRE)--Intelligent Medical Objects (IMO), a healthcare data enablement company, conducted a survey of more than 300 provider leaders who are responsible for implementing and ...

Intelligent Medical Objects, a Rosemont-based medical data company, has sold a majority stake to Boston-based private-equity firm Thomas H. Lee Partners in a deal worth more than $1.5 billion. The ...